AI Article Synopsis

  • Hypertrichosis is an abnormal increase in body hair, with severe cases known as Were Wolf Syndrome, affecting hair on any part of the body and resulting in longer and darker hairs.
  • The condition can be congenital or acquired, as seen in a case of an 8-year-old boy diagnosed with Were Wolf Syndrome after ruling out other causes of his excessive body hair.
  • The boy had developmental delays and epilepsy, and he received treatment that included developmental stimulation and anti-epileptic medication before being discharged with proper counseling.

Article Abstract

Hypertrichosis is abnormal increase in body hair, when it becomes extensive known as Were Wolf Syndrome. Any part of body can be affected and body hairs are longer and darker. Hairs may be of any type like lanugo, vellous or terminal. It may be present since birth or may occur later in life. A 8 years old boy was admitted in our hospital with excess body hair, he was diagnosed as a case of Were Wolf syndrome after excluding possible acquired causes of hypertrichosis. He had history of delayed developmental milestone and has been suffering from epilepsy. He was treated with developmental stimulation and anti epileptic drug. Then he was discharged after proper counseling.

Download full-text PDF

Source

Publication Analysis

Top Keywords

wolf syndrome
12
body hair
8
congenital hypertrichosis
4
hypertrichosis wolf
4
syndrome case
4
case report
4
report hypertrichosis
4
hypertrichosis abnormal
4
abnormal increase
4
body
4

Similar Publications

Background: Foot drop is a common condition for patients with upper motor neuron syndrome such as cerebral palsy (CP). This study aimed to investigate the effects of functional electrical stimulation (FES) on gait function, quality of life, and FES satisfaction in adults with CP and foot drop. To analyze effects over time, an observational, longitudinal study was performed.

View Article and Find Full Text PDF

Art therapy and brain injury: making the invisible visible.

Front Psychol

December 2024

College of Nursing and Health Professions, Art Therapy and Counseling, Drexel University, Philadelphia, PA, United States.

The multiple cognitive, somatic, and behavioral changes following head injuries can result in expressive language difficulties that may not be resolved quickly. This paper explores the traumatic brain injury and post-concussive syndrome artwork created by an art therapist and the child of an art therapist, making the invisible neurological consequences of head injuries visible. Our first-person and caregiver perspectives offer examples of visual arts-based communication between patients, health professionals, and family members.

View Article and Find Full Text PDF

Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). Here, we present a case of a patient with Lennox-Gastaut Syndrome (LGS) treated with fenfluramine with development of PAH and tricuspid regurgitation that resolved upon discontinuation.

View Article and Find Full Text PDF

Objective: Lennox-Gastaut Syndrome (LGS) is a severe, often treatment-resistant epilepsy syndrome typically diagnosed in early childhood. Many have seizures before diagnosis. Some have periods of seizure freedom before treatment resistance, i.

View Article and Find Full Text PDF

interference leading to erroneous identification of a pathogenic variant in Black patients.

Genet Med Open

June 2024

Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

This study investigates the frequency of a clinically reported variant in , NM_000535.7:c.2523G>A p.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!